doi: 10.1007/s13679-025-00624-0
There is a subtler point buried in the KPV mechanism that undercuts its use in an injected blend
Type 1 DM Autoimmune destruction of pancreatic beta cells absolute insulin deficiency
Concerning reactions that warrant medical review: Progressive swelling increasing size of a lump or swelling over 2448 hours Persistent redness redness that spreads beyond the immediate injection site or intensifies rather than fading Warmth and pain the injection site feels hot to touch and becomes increasingly painful, suggesting possible infection (cellulitis) Systemic symptoms fever, chills, or feeling generally unwell following an injection Allergic-type reactions hives, itching, or rash developing at or beyond the injection site Severe, persistent abdominal pain especially if radiating to the back, with or without vomiting (possible pancreatitis) Jaundice yellowing of the skin or eyes, which could indicate gallbladder problems (a known risk with Saxenda) It is important to note that there is no official link between Saxenda and increased bleeding disorders or coagulopathy
GLP-1 Drugs and Gastroparesis: What Victims Need to Know Key Takeaways Gastroparesis, or stomach paralysis, has emerged as a significant medical complication linked to GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro
Gut Microbes 14 , 2050635 (2022)
